Federal award (DELIVERY ORDER, fiscal year 2024)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2024-11-25 to 2024-11-26
Current total value of award: $41466.56
Description: 4566543963!ADBRY 150 MG/ML SYRINGEML